High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey

Difference in prevalence of metabolic syndrome between Japanese outpatients and inpatients with schizophrenia: A nationwide survey

(2016) Takuro Sugai et al.   SCHIZOPHRENIA RESEARCH

High Prevalence of Obesity, Hypertension, Hyperlipidemia, and Diabetes Mellitus in Japanese Outpatients with Schizophrenia: A Nationwide Survey

(2016) Takuro Sugai et al.   PLoS One

Metabolic Disturbances Independent of Body Mass in Patients with Schizophrenia Taking Atypical Antipsychotics

(2015) Shi Hyun Kang et al.   Psychiatry Investigation

Metabolic syndrome in drug-naïve and drug-free patients with schizophrenia and in their siblings

(2015) Aslı Enez Darcin et al.   SCHIZOPHRENIA RESEARCH

Metabolic syndrome in people with schizophrenia: a review

(2015) MARC DE HERT et al.   World Psychiatry

High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia

(2013) Yutaro Suzuki et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Differential Effects of Aerobic Exercise, Resistance Training and Combined Exercise Modalities on Cholesterol and the Lipid Profile: Review, Synthesis and Recommendations

(2013) Steven Mann et al.   SPORTS MEDICINE

Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics

(2012) Franca Centorrino et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Body Mass Index of Inpatients with Schizophrenia in Japan

(2012) Yukiko Inamura et al.   INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE

A Double Blind, Placebo-Controlled, Randomized Crossover Study of the Acute Metabolic Effects of Olanzapine in Healthy Volunteers

(2011) Vance L. Albaugh et al.   PLoS One

Association of Body Mass Index and Lipid Profiles: Evaluation of a Broad Spectrum of Body Mass Index Patients Including the Morbidly Obese

(2010) Lior Shamai et al.   OBESITY SURGERY

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis

(2010) Christine Rummel-Kluge et al.   SCHIZOPHRENIA RESEARCH

Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review

(2009) Diana R. Chirovsky et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent?

(2009) Viktoria Simon et al.   JOURNAL OF CLINICAL PSYCHIATRY

Dyslipidemia Independent of Body Mass in Antipsychotic-Treated Patients Under Real-Life Conditions

(2009) Astrid B. Birkenaes et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The metabolic syndrome and schizophrenia

(2008) J. M. Meyer et al.   ACTA PSYCHIATRICA SCANDINAVICA

A Double-Blind, Randomized Comparative Study of Aripiprazole and Olanzapine in Patients with Schizophrenia

(2008) W. Wolfgang Fleischhacker et al.   BIOLOGICAL PSYCHIATRY

Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population

(2008) Rocio Perez-Iglesias et al.   SCHIZOPHRENIA RESEARCH